Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902
Titel:
Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902
Auteur:
Sugawara, S. Oizumi, S. Minato, K. Harada, T. Inoue, A. Fujita, Y. Maemondo, M. Yoshizawa, H. Ito, K. Gemma, A. Nishitsuji, M. Harada, M. Isobe, H. Kinoshita, I. Morita, S. Kobayashi, K. Hagiwara, K. Kurihara, M. Nukiwa, T.